BMGF – Gates Foundation  [to 23 September 2017] Releases
SEPTEMBER 20, 2017
Bill and Melinda Gates Host Inaugural ‘Goalkeepers’ Event to Engage a New Generation of Leaders in the Fight Against Poverty and Disease
Prime Minister Trudeau and President Obama join other leaders from business, technology, media and entertainment to help speed progress toward the ‘Global Goals’

EDCTP    [to 23 September 2017]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
20 September 2017
Nigeria becomes 29th member of EDCTP
EDCTP is pleased to welcome Nigeria as its 29th member country.  As a member of the EDCTP Association, it will…
Gavi [to 23 September 2017]
18 September 2017
Cholera vaccination campaign begins in north-eastern Nigeria
Mass vaccination effort will target over 915,000 people to contain cholera outbreak in Borno state.
[See Cholera above for more detail]
GHIT Fund   [to 23 September 2017]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical ·
Event Report: World Leaders for Universal Health Coverage (UHC): A High-Level Discussion at the United Nations on Achieving the SDGs Through Health for All

On September 18, leaders from the GHIT Fund attended, an event convened on the sidelines of the 72nd United Nations General Assembly in New York City. Dr. Kiyoshi Kurokawa, Chair of the GHIT Fund, served as a featured speaker.
MSF/Médecins Sans Frontières  [to 23 September 2017]
Press release
Nigeria: MSF Scales Up Activities as Cholera Outbreak Continues to Spread Across Borno State
September 18, 2017
As new cases of cholera emerge in Monguno, Dikwa, and Maiduguri, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) continues to scale up its response in Borno state, including recently opening an additional cholera treatment unit (CTU) near Muna Garage camp.
NIH  [to 23 September 2017]
September 20, 2017
Immune cells may heal bleeding brain after strokes
NIH-funded preclinical rodent study points to neutrophils for potential treatment options.

September 20, 2017
Three-in-one antibody protects monkeys from HIV-like virus
NIH and Sanofi scientists prepare to test antibody in people.
PATH  [to 23 September 2017]
Press release | September 17, 2017
New global coalition will boost access to medicines and products for chronic diseases
The coalition, led by PATH, brings together multisectoral partners to reduce the toll of noncommunicable diseases, including diabetes, hypertension, and cardiovascular disease.
New York, September 18, 2017—A multisectoral partnership today launched a first-of-its-kind global coalition dedicated to increasing access to essential medicines and health products to prevent and treat noncommunicable diseases (NCDs) and conditions, including diabetes, hypertension, and cardiovascular disease.
The new Coalition for Access to NCD Medicines & Products brings together governments, the private sector, philanthropic and academic institutions, and nongovernmental organizations to tackle barriers countries face in procuring, supplying, and distributing essential medicines and technologies and ensuring they are used effectively. PATH will serve as the coalition secretariat.
The coalition will partner with countries to help them achieve the World Health Organization target of 80 percent availability of affordable technologies and essential medicines, including generics, required to treat NCDs in both public and private facilities.
The launch event, alongside the United Nations General Assembly in New York, features an interactive panel of global health leaders and influencers from across sectors sharing their perspectives on the opportunities ahead to reduce the toll of NCDs….

UNAIDS [to 23 September 2017]
Press release
New high-quality antiretroviral therapy to be launched in South Africa, Kenya and over 90 low-and middle-income countries at reduced price
   [Undated] New York – A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and middle-income countries (LMICs) at around US$75 per person, per year. The agreement is expected to accelerate treatment rollout as part of global efforts to reach all 36.7 million people living with HIV with high-quality antiretroviral therapy. UNAIDS estimates that in 2016, just over half (19.5 million) of all people living with HIV had access to the lifesaving medicines.
DTG, a best-in-class integrase inhibitor, is widely used in high-income countries and is recommended by the World Health Organization (WHO) as an alternative first-line HIV regimen, as well as a preferred treatment by the U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, among many others. In addition to improving treatment quality and retention, widespread use of DTG is expected to lower the cost of first-line HIV treatment regimens while also reducing the need for more expensive second- and third-line regimens. In July 2017, WHO issued guidance to countries on how to safely and rapidly transition to DTG-based antiretroviral treatment.
This agreement, announced by the governments of South Africa and Kenya, together with the Joint United Nations Programme on HIV/AIDS (UNAIDS), the Clinton Health Access Initiative (CHAI), the Bill & Melinda Gates Foundation (BMGF), Unitaid, the United Kingdom’s Department for International Development (DFID), the United States President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. Agency for International Development (USAID), and the Global Fund to Fight AIDS, Tuberculosis and Malaria, with Mylan Laboratories Limited and Aurobindo Pharma, takes an important step toward ensuring the availability of worldwide high-quality treatment for HIV.
“This agreement will improve the quality of life for millions of people living with HIV,” said UNAIDS Executive Director Michel Sidibé. “To achieve the 90-90-90 treatment targets, newer, affordable and effective treatment options must be made available—from Baltimore to Bamako—without any delay.”…

Press release
UNAIDS calls to quicken the pace of action to end AIDS
World leaders come together to renew the urgency around ending AIDS as part of the Sustainable Development Goals
GENEVA/NEW YORK, 21 September 2017—The President of Uganda, Yoweri Museveni, in collaboration with UNAIDS, brought together six heads of state or government to accelerate action and get countries on the Fast-Track to end AIDS. World leaders joined around 500 partners from government, the private sector and civil society on the sidelines of the United Nations General Assembly to reinvigorate political leadership around HIV.
The Fast-Track approach is saving more and more lives. In 2016, 19.5 million people—more than half the 36.7 million people living with HIV—were accessing life-saving treatment. The number of people who died from AIDS-related illnesses has been reduced by nearly half since 2005, and the global number of new HIV infections has been reduced by 11% since 2010.
However, the pace of action is still not enough to end the AIDS epidemic as a public health threat by 2030…

UNICEF  [to 23 September 2017]
23 September 2017
Education at risk for thousands of children after successive earthquakes in Mexico – UNICEF
MEXICO CITY/NEW YORK, 23 September 2017 – Nearly 5,100 schools have been damaged or destroyed in Mexico following two powerful earthquakes that struck less than two weeks apart, threatening access to education for thousands of children – UNICEF said today.

Region of the Americas eliminates maternal and neonatal tetanus
WASHINGTON/NEW YORK, 21 September 2017 – The Region of the Americas has eliminated maternal and neonatal tetanus (MNT), a disease that used to be responsible for the deaths of more than 10,000 newborns every year in the Americas.
[See Milestones above for more detail]

Only 15 countries worldwide have three essential national policies that support families with young children – UNICEF
NEW YORK, 21 September 2017 – Only 15 countries worldwide have three basic national policies that help guarantee the time and resources parents need to support their young children’s healthy brain development, UNICEF said today in a new report. Worse, 32 countries – home to one in eight of the world’s children under five – have none of these policies in place.

The Vaccine Confidence Project  [to 23 September 2017]
Confidence Commentary:
Harnessing innovation in public health
17 Sep 2017
The second Raffles Dialogue, hosted last week by the National University of Singapore schools of medicine, public health and public policy along with the National University Health System (NUHS), focused on “The Critical Role of Innovation” in the context of the broader theme of “Human Well-being and Security in 2030”.
It was attended by more than 100 global health experts and international participants.
In his opening address looking forward to 2030, Professor John Wong, chief executive of NUHS, urged the audience to consider Charles Darwin’s theory of natural selection, published in the mid-1800s, which emphasised that neither intelligence nor physical strength was the critical factor for survival.
Instead, the key to survival is the ability to adapt to change. More than 200 years later, this need to adapt is more pressing than ever…
The dialogue explored innovations in health, information and big data, financing and global governance. In the face of fast paced change, how will all this innovation weave together? How can societies ensure that the innovations are harnessed for positive disruptions, and not negative ones? How can these innovations help to advance equity, rather than drive inequities, with some benefiting more than others?
Wellcome Trust  [to 23 September 2017]
News / Published: 21 September 2017
Superbug’s spread to Vietnam threatens malaria control
A highly drug-resistant strain of malaria has spread from western Cambodia to southern Vietnam.
Wellcome researchers warn that the spread of artemisinin drug-resistant Plasmodium falciparum C580Y is leading to alarming failure rates for Vietnam’s first-line malaria treatment – dihydroartemisinin (DHA)-piperaquine.
In a letter published in The Lancet Infectious Diseases (opens in a new tab), the scientists say the spread of the malaria superbug across the entire Mekong Sub-region, from western Cambodia to north-eastern Thailand, southern Laos and now into southern Vietnam, poses an urgent threat to malaria control…
News / Published: 20 September 2017
Genome editing sheds light on human embryo development
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development.
It’s the first time that editing of the genome – the complete set of genes in a cell or organism – has been used to study gene function in human embryos.
The research could help scientists to better understand the biology of our early development…
Opinion / Published: 20 September 2017
Director’s update: sustaining a historically high spending level for Wellcome
In the next year, Wellcome will support more science, research and public engagement than ever before, spending over £1 billion on the people, places and projects that advance our mission of improving health by helping great ideas to thrive…
DCVMN – Developing Country Vaccine Manufacturers Network  [to 23 September 2017]
25 September 2017 to 28 September 2017
DCVMN Annual General Meeting
Seoul / Korea
Download the Agenda